6-ketoprostaglandin-f1-alpha and Carcinosarcoma

6-ketoprostaglandin-f1-alpha has been researched along with Carcinosarcoma* in 1 studies

Other Studies

1 other study(ies) available for 6-ketoprostaglandin-f1-alpha and Carcinosarcoma

ArticleYear
[Correlation between TXB2, 6-Keto-PGF1alpha and liver metastasis in rats model with blood stasis].
    Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine, 2003, Volume: 1, Issue:3

    To observe the correlation between serum level of TXB2, 6-Keto-PGF1alpha and liver metastasis.. The metastatic model was made by injection of W256 carcinosarcoma. Rats were randomly divided into two groups: rats with blood stasis group and control group. Rats in control group were given normal saline via abdominal cavity once a day. Rats in blood stasis group were injected adrenalin in the fourteenth day. Tumor size and liver metastasis were observed. Serum TXB2 and 6-Keto-PGF1alpha were tested by radioimmunoassay.. Tumor size in rats with blood stasis was significantly smaller than that of the control group (P<0.01). Occurrence of liver metastasis in rats with blood stasis was significantly lower than that of the control group (P<0.01). The values of 6-Keto-PGF1alpha, TXB2, and TXB2/6-Keto-PGF1alpha were higher in the group with blood stasis.. In the status of blood stasis, W256 carcinosarcoma grows slowly, and liver metastasis increases insignificantly, with the elevations of 6-Keto-PGF1alpha, TXB2 and TXB2/6-Keto-PGF1alpha.

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Carcinosarcoma; Cell Line, Tumor; Disease Models, Animal; Liver Neoplasms, Experimental; Male; Medicine, Chinese Traditional; Rats; Rats, Wistar; Thromboxane B2

2003